Format

Send to

Choose Destination
ACS Appl Mater Interfaces. 2019 Feb 27;11(8):7774-7781. doi: 10.1021/acsami.8b21280. Epub 2019 Feb 18.

Renal Clearable Bi-Bi2S3 Heterostructure Nanoparticles for Targeting Cancer Theranostics.

Dong L1,2, Zhang P3, Liu X2, Deng R1, Du K1,2, Feng J1,2, Zhang H1,2.

Author information

1
State Key Laboratory of Rare Earth Resource Utilization , Changchun Institute of Applied Chemistry, Chinese Academy of Sciences , Changchun , Jilin 130022 , People's Republic of China.
2
University of Science and Technology of China , Hefei , Anhui 230026 , People's Republic of China.
3
Department of Radiology , The Second Hospital of Jilin University , Changchun , Jilin 130041 , People's Republic of China.

Abstract

Recent development of precise nanomedicine has aroused an overwhelming interest in integration of diagnosis and treatment for cancers. Designing renal-clearable and targeting nanoparticles (NPs) has specific cancer theranostic implications and remains a challenging task. In this work, the ultrasmall folic acid (FA) and bovine serum albumin-modified Bi-Bi2S3 heterostructure nanoparticles NPs (Bi-Bi2S3/BSA&FA NPs) with excellent computed tomography (CT) and photoacoustic imaging abilities and outstanding photothermal performances were synthesized in an aqueous phase route via a simple method. Bi-Bi2S3/BSA&FA NPs have the following criteria: (i) Bi-Bi2S3/BSA&FA NPs with heterostructure possess better stability than Bi NPs and higher Bi content than Bi2S3 NPs, which are conducive to the enhancement of CT imaging effect; (ii) Bi-Bi2S3/BSA&FA NPs with FA molecules on the surface could target the tumor site effectively; (iii) Bi-Bi2S3/BSA&FA NPs could inhibit tumor growth effectively under 808 nm laser irradiation; (iv) ultrasmall Bi-Bi2S3/BSA&FA NPs could be cleared through kidney and liver within a reasonable time, avoiding a long-term retention/toxicity. Therefore, the renal clearable Bi-Bi2S3/BSA&FA NPs are a promising agent for targeting cancer theranostics.

KEYWORDS:

Bi−Bi2S3 heterostructure; CT imaging; photoacoustic imaging; photothermal therapy; renal clearable; targeting theranostic agent

PMID:
30698406
DOI:
10.1021/acsami.8b21280

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center